Amble Health vs Found vs Lavender Sky Health (2026)
On tirzepatide, the order is Found ($289) → Amble Health ($300) → Lavender Sky Health↗ ($352) — gaps of $11 and then $52 a month, a $756 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
The three records, one screen
Found: the record, condensed
Found’s tirzepatide program bills $289 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $289 is the whole subscription, which makes Found unusually easy to compare and unusually easy to leave.
To place the number: #6 of 17 verified programs, with the floor $74/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $160 a month. A year at this figure: $3,468 monthly-billed.
Found’s semaglutide program bills $289 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Found is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $289 is the whole subscription, which makes Found unusually easy to compare and unusually easy to leave.
Context for that figure: it ranks #15 of 20 in the verified semaglutide index — $156/month above the floor (Oak Longevity, $133) — and sits $60 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $3,468.
Operationally at Found: shipping included; commitment none month-to-month; prepaid terms for lowest rate; cancellation membership recurs; prepaid terms are paid up front; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Found page · visit Found ↗
Amble Health: the record, condensed
Amble Health’s tirzepatide program bills $300 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Amble Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $300 is the whole subscription, which makes Amble Health unusually easy to compare and unusually easy to leave.
To place the number: #9 of 17 verified programs, with the floor $85/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $149 a month. A year at this figure: $3,600 monthly-billed.
Operationally at Amble Health: shipping unknown; commitment unknown; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Amble Health page
Lavender Sky Health: the record, condensed
Start with the load-bearing figure: $352 a month, all-in, is what Lavender Sky Health charges for tirzepatide at the 10 mg basis. Pricing steps with the dose here: from $200 at entry to $352 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $1,824 a year, which is why every ranking on this site uses the larger number.
A required $25/month membership is part of the deal, and part of the figure above: $327 of medication plus $25 of platform equals the $352 that leaves your account. Judge the membership by what it includes, but compare on the total.
To place the number: #12 of 17 verified programs, with the floor $137/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $97 a month. A year at this figure: $4,224 monthly-billed.
Lavender Sky Health’s semaglutide program bills $174 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.
The all-in figure already contains a compulsory $25 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $149 would be exactly that kind of mirage.
Context for that figure: it ranks #6 of 20 in the verified semaglutide index — $41/month above the floor (Oak Longevity, $133) — and sits $175 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,088.
Operationally at Lavender Sky Health: shipping included; commitment monthly plan fee recurs; cancellation plan fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Lavender Sky Health page · visit Lavender Sky Health ↗
Prices, gaps, and what sits inside them
Found holds the low ground at $289 — dose-flat, so that figure is a ceiling with no membership attached. Amble Health follows at $300 (+$11/mo, $132/yr). Lavender Sky Health tops the trio at $352 (+$63/mo over the leader, $756/yr) — note its record’s watch-out below.
The semaglutide picture reshuffles the order: Lavender Sky Health $174 → Found $289 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.
Who wins what
Cheapest month-to-month: Found ($289); cheapest 12-month path: Found ($3,468); simplest billing (no membership): Found and Amble Health; dose-flat structure: Found and Amble Health; cheapest semaglutide of the three: Lavender Sky Health ($174).
Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Found vs Amble Health (record · record) · Found vs Lavender Sky Health (record · record) · Amble Health vs Lavender Sky Health (record · record).
Everything besides the three prices
Memberships: Found none; Amble Health none; Lavender Sky Health $25/mo (inside its figure). Structures: Found dose-flat; Amble Health dose-flat; Lavender Sky Health step/tiered. Pharmacies: Found not named; Amble Health not named; Lavender Sky Health not named. States: Found — most states; Amble Health — not published; Lavender Sky Health — not published. Exit terms: Found — membership recurs; prepaid terms are paid up front; Amble Health — not published; Lavender Sky Health — plan fee recurs until cancelled.
The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Found third-party reported (2026-08-05); Amble Health third-party reported (2026-08-05); Lavender Sky Health source-verified (2026-08-05).
The trio on semaglutide, across time
3 mo: Lavender Sky Health $522 vs Found $867 6 mo: Lavender Sky Health $1,044 vs Found $1,734 12 mo: Lavender Sky Health $2,088 vs Found $3,468 — monthly-billed totals; prepaid paths where published appear on each provider page.
The trio, annualized
Found: $3,468/yr monthly-billed; Amble Health: $3,600/yr monthly-billed; Lavender Sky Health: $4,224/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,512 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.
The elimination read
A three-way choice is really two eliminations, so run them in order. Eliminate Lavender Sky Health first unless it names its edge: at $352 it carries a $63/month premium over the floor of this trio — $756 a year, about 2.6 extra months of therapy at Found’s rate — and a premium that size must point at a specific line in its record (the services inside its $25/mo membership) or it is decoration. Then interrogate Amble Health’s middle ground: nothing structural — its case is purely situational; if that specific thing is on your personal ledger, the $11/month over the floor can be rational — if not, the middle is where budgets go to leak. What survives is Found at $289, which wins by default rather than by argument — exactly how a price index should crown things — subject to the two checks no ranking can run for you: your state at intake, and your prescriber on the medication itself.
The same trio on best published rate: Found $289 → Amble Health $300 → Lavender Sky Health $352 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Found $867, Amble Health $900, Lavender Sky Health $1,056; 6 months — Found $1,734, Amble Health $1,800, Lavender Sky Health $2,112. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.
The record-quality read, scored on the five checkable disclosures this index tracks (maintenance price, named pharmacy, published states, published cancellation terms, source-verified capture): Found 3/5, Amble Health 3/5, Lavender Sky Health 4/5. Lavender Sky Health discloses the most and Found the least, and in this market disclosure predicts disclosure — the axis where a program goes quiet is reliably where its checkout surprises live. The three match on every disclosure axis, which is rare and worth noting in their favor collectively. Scores recompute from the public records like everything else here.
Read as a decision: start from Found and make the other two argue upward. Amble Health’s case is its structure; Lavender Sky Health’s case must be worth $756 a year in named features — the honest unit being months of medication (2.6 of them at the floor rate). The pairwise pages above hold each argument in full, and the calculator holds your version of it.
Frequently asked
Which is cheapest: Amble Health, Found, or Lavender Sky Health?
Found, at $289/month all-in tirzepatide — $11 under Amble Health and $63 under Lavender Sky Health; on semaglutide the cheapest of the three is Lavender Sky Health at $174. Captured 2026-08-09.
Which of the three is best over a full year?
Found’s best path prices twelve months at $3,468; monthly-billed years run Found $3,468, Amble Health $3,600, Lavender Sky Health $4,224.
Are these rankings paid or editorial?
Neither — they are sorts of the public dataset on the all-in maintenance basis, regenerated on every data change; the methodology page defines the basis and the JSON lets you recompute every figure here.